Clinical Trials Directory

Trials / Completed

CompletedNCT00529217

Treatment of Depersonalization Disorder With Transcranial Magnetic Stimulation (TMS)

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
10 (actual)
Sponsor
New York State Psychiatric Institute · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the clinical efficacy of transcranial magnetic stimulation in the treatment of Depersonalization Disorder (DPD).

Detailed description

This study is a research trial of an outpatient, non-medication, non-invasive investigational treatment called Transcranial Magnetic Stimulation (TMS). TMS applies a magnetic field to the brain for a brief period of time. TMS is a procedure that involves 30 minute-long daily sessions every weekday for a series of weeks. The investigators are testing whether TMS can treat Depersonalization Disorder (DPD). This is an open-label study. All patients will receive active treatment. DPD symptoms will be monitored through weekly self-report questionnaires as well clinical ratings with a doctor.

Conditions

Interventions

TypeNameDescription
DEVICERepetitive Transcranial Magnetic Stimulation (rTMS)Strong electromagnetic fields (\~2Tesla) generated briefly (\~1ms) but repetitively (1Hz) applied for 30mins, in five sessions per week for up to twelve weeks.

Timeline

Start date
2006-05-01
Primary completion
2010-09-01
Completion
2010-10-01
First posted
2007-09-14
Last updated
2014-09-22
Results posted
2014-09-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00529217. Inclusion in this directory is not an endorsement.